Recent research focusing on Semaglutide at a dosage of 20mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may amplify the drug's ability to manage blood sugar, potentially offering improved outcomes for individuals with type 2 diabetes. Further study is underway to fully understand the long-term